Welcome to our dedicated page for Integer Hldgs news (Ticker: ITGR), a resource for investors and traders seeking the latest updates and insights on Integer Hldgs stock.
Integer Holdings Corporation (NYSE: ITGR) is a medical device contract development and manufacturing organization (CDMO) that regularly issues news on its operations, financial performance, and corporate developments. The company focuses on serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets, and its updates reflect activity across these areas.
On this page, readers can follow ITGR news related to quarterly earnings, product line performance, and outlooks that Integer provides through press releases furnished with Form 8-K filings. These releases often include discussions of sales trends in Cardio & Vascular, Cardiac Rhythm Management & Neuromodulation, and Other Markets, along with non-GAAP financial measures such as adjusted operating income, adjusted EBITDA, adjusted net income, and adjusted earnings per share.
Integer’s news flow also covers strategic and governance events, such as leadership transitions, board appointments, and capital allocation decisions. Recent examples include the appointment of a new President and Chief Executive Officer, the election of a new director with extensive medical device industry experience, and the authorization of a share repurchase program by the Board of Directors.
In addition, Integer publishes updates on technology and market-facing activities, such as participation in medical society meetings and healthcare investor conferences. The company has highlighted innovations in neuromodulation and miniaturized active implantable medical devices, including high-performance batteries and integrated implantable pulse generator and lead systems, as well as its Xcellion Gen 3 fast charge lithium ion battery technology.
Investors and observers can use this news page to monitor how Integer communicates its strategy, product line dynamics, financing actions, and role as a CDMO in the cardiac rhythm management, neuromodulation, and cardio and vascular markets.
Integer Holdings (NYSE:ITGR) has scheduled its second quarter 2025 earnings conference call for Thursday, July 24, 2025, at 8 a.m. CT / 9 a.m. ET. The company will release its Q2 2025 financial results prior to the call on the same day.
The conference call will be accessible via webcast and telephone, with domestic dial-in at (800) 715-9871 and international dial-in at (646) 307-1963 using Conference ID 3120125. An audio replay will be available for seven days following the call.
Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), has announced its upcoming participation in the 2025 Bank of America Securities Health Care Conference.
The conference is scheduled for May 13-15, 2025, in Las Vegas. Integer's executive leadership team will engage in a fireside chat presentation on Wednesday, May 14, at 10:00 a.m. PT.
Investors and interested parties can access a live webcast of the presentation through the "News & Events" section on Integer's Investor Relations website at investor.integer.net.
Integer Holdings (NYSE: ITGR) announced a leadership transition as Joseph Dziedzic plans to retire as President and CEO effective October 24, 2025. Payman Khales, current Chief Operating Officer, will succeed as President and CEO and join the Board of Directors.
Under Dziedzic's eight-year tenure, Integer focused on high-growth markets, enhanced investment in differentiated technologies, and implemented the Integer Production System. Khales, who joined in 2018 as President of Cardio & Vascular business, has demonstrated strong leadership by doubling the division's sales in seven years and achieving above-market growth. As COO, he currently oversees both Cardio & Vascular and Cardiac Rhythm Management & Neuromodulation business units.
To ensure a smooth transition, Dziedzic will serve as an advisor through March 31, 2026.
Integer Holdings (NYSE:ITGR) reported strong Q1 2025 results with sales increasing 7% to $437 million and organic growth of 6%. The company's GAAP operating income rose 28% to $50 million, while adjusted operating income grew 14% to $71 million.
Key highlights include Cardio & Vascular sales growth of 17% and Cardiac Rhythm Management & Neuromodulation sales increase of 2%. The company completed a $1.0 billion convertible notes offering, expecting $13 million reduction in interest expense for 2025.
Integer updated its 2025 outlook, projecting sales growth of 8-10% ($1.846-1.880 billion) and raising adjusted net income growth outlook to 19-26%. The company also announced CEO Joseph Dziedzic's planned retirement, with COO Payman Khales set to assume the position in October 2025.
Integer Holdings (NYSE: ITGR), a contract development and manufacturing organization, has issued a statement regarding the impact of recent trade policy developments and tariffs on its business. The company expects the announced tariffs to have an immaterial impact on its 2025 results.
CEO Joseph Dziedzic stated that the company estimates a $1 to $5 million impact on full-year adjusted operating income, which accounts for currently applicable tariffs and additional tariffs announced on April 2 following a 90-day pause. This estimate includes both implemented and planned mitigation actions. Integer will release its Q1 2025 financial results on April 24, 2025.
Integer Holdings (NYSE: ITGR) has announced that holders of its 2.125% Convertible Senior Notes due 2028 can now convert their notes from April 1, 2025, to June 30, 2025. The conversion opportunity arose because the company's stock price exceeded 130% of the conversion price for at least 20 trading days within a 30-day trading period ending March 31, 2025.
The notes are convertible into cash up to the principal amount, and the remainder can be settled in cash, shares, or a combination thereof at Integer's discretion. The conversion rate is set at 11.4681 shares of common stock per $1,000 principal amount, equivalent to a conversion price of approximately $87.20 per share.
Integer Holdings (NYSE: ITGR) has announced its upcoming first quarter 2025 earnings release and conference call schedule. The company will release its financial and operational results on Thursday, April 24, 2025 at 7 a.m. Central Time / 8 a.m. Eastern Time.
Management will host a webcast at 8 a.m. CT / 9 a.m. ET to discuss the quarterly results. The conference call will be accessible via domestic dial-in (800-715-9871) and international dial-in (646-307-1963) using Conference ID 3120125. An audio replay will be available for seven days following the call.
Integer Holdings (NYSE: ITGR) has successfully closed a $1.0 billion convertible senior notes offering due 2030, with a 1.875% interest rate. The offering was upsized from the initial $750 million due to strong investor demand, with initial purchasers exercising their option for an additional $125 million.
The company expects net proceeds of $976.1 million after expenses, which will be used to pay for capped call transactions, exchange existing convertible notes, and repay revolving credit facility and term A loan borrowings. The transaction is projected to generate $12 million in interest expense savings for 2025.
The notes' conversion structure includes cash payment for the principal amount and protection against dilution through capped call transactions, setting an effective conversion price of $189.44, representing a 60% premium over the March 13, 2025 closing stock price of $118.40.
Integer Holdings (NYSE: ITGR) has announced the pricing of $875.0 million convertible senior notes due 2030, upsized from the previously announced $750.0 million. The notes will carry a 1.875% interest rate and mature on March 15, 2030.
The company expects net proceeds of approximately $853.9 million (or $976.1 million if the initial purchasers exercise their additional notes option). Integer will use about $62.1 million for capped call transactions and $384.4 million to exchange approximately $383.7 million of existing 2.125% convertible notes due 2028.
The notes will be convertible at an initial rate of 6.6243 shares per $1,000 principal amount, equivalent to a conversion price of $150.96 per share, representing a 27.5% premium over the March 13, 2025 closing price of $118.40.
FAQ
What is the current stock price of Integer Hldgs (ITGR)?
What is the market cap of Integer Hldgs (ITGR)?
